NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE147840 Query DataSets for GSE147840
Status Public on Mar 01, 2021
Title N1-methyladenosine methylations in tRNA drive liver tumorigenesis by PPARĪ“-mediated cholesterol synthesis
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Other
Non-coding RNA profiling by high throughput sequencing
Summary Increased protein translation plays a critical role in cancer development and treatment1,2. However, the molecular mechanism that is involved in this process remains poorly understood. N1-methyladenosine (m1A) methylation in RNA accounts for regulating mRNA translation in a post-transcriptional manner3,4. Here we show that m1A methylation levels are remarkably elevated in hepatocellular carcinoma (HCC) patient tumor tissues, especially in patients with microscopic vascular invasion (MVI). Moreover, m1A methylation signals are increased in liver cancer stem cells (CSCs) and are negatively correlated with HCC patient survival. Consistently, TRMT6 and TRMT61A, forming m1A methyltransferase complex, are highly expressed in advanced HCC tumors and are negatively correlated with HCC survival. TRMT6/TRMT61A-mediated m1A methylations are required for self-renewal of liver CSCs and tumorigenesis. Mechanistically, TRMT6/TRMT61A-dependent m1A in tRNA boost PPARĪ“ expression, which triggers cholesterol synthesis to activate Hedgehog signaling, driving self-renewal of liver CSCs and tumorigenesis. For potential therapeutic benefit, we further identify a specific inhibitor against TRMT6/TRMT61A complex that exerts effective therapeutic effect on liver cancer with high m1A methylations. Our findings provide novel insights into the function and molecular mechanism of m1A modifications underlying liver tumorigenesis and drug target, which will serve as a new biomarker for HCC and pave a new way to develop more effective therapeutic strategies for HCC patients.
 
Overall design We find that the overall m1A methylation signal as well as the relevant m1A-methyltransferase TRMT6/61A are of abberrently high level in HCC tumor samples. By performing m1A sequencing for small RNA populations, we discovered several tRNAs with elevated m1A58 methylation stoicheometry. Then we evaluate the influenences on gene expression via Ribo-seq, and proved that TRMT6/TRMT61A-dependent m1A in tRNA boost expression of some metabolic pathway genes, which trigger cholesterol synthesis to activate Hedgehog signaling, driving self-renewal of liver CSCs and tumorigenesis.
 
Contributor(s) Wang Y, Li X, Xiong X, Yi C, Fan Z
Citation(s) 34728628
Submission date Mar 31, 2020
Last update date Nov 30, 2021
Contact name Xushen Xiong
E-mail(s) xiongxs@zju.edu.cn
Organization name Zhejiang University
Department Medical Center
Street address Wenyi Road West
City Hangzhou
State/province Zhejiang
ZIP/Postal code 311121
Country China
 
Platforms (2)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
GPL23227 BGISEQ-500 (Homo sapiens)
Samples (8)
GSM4446977 PLC_m1Aseq
GSM4446978 PLCStem_m1Aseq
GSM4446979 AlkB-PLC_m1Aseq
Relations
BioProject PRJNA622261
SRA SRP254791

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE147840_AlkB-PLCStem_m1Aseq.mismatch.xls.gz 270.7 Kb (ftp)(http) XLS
GSE147840_AlkB-PLC_m1Aseq.mismatch.xls.gz 265.3 Kb (ftp)(http) XLS
GSE147840_PLC.TE.xls.gz 1020.2 Kb (ftp)(http) XLS
GSE147840_PLCStem_m1Aseq.mismatch.xls.gz 209.4 Kb (ftp)(http) XLS
GSE147840_PLC_m1Aseq.mismatch.xls.gz 206.6 Kb (ftp)(http) XLS
GSE147840_PLC_stem.TE.xls.gz 1.0 Mb (ftp)(http) XLS
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap